dehydroepiandrosterone has been researched along with Urge Incontinence in 2 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to compare the efficacy of the transobturator tape (TOT) procedure combined with solifenacin (TOT-S) or prasterone (TOT-P) in postmenopausal women affected by mixed urinary incontinence (MUI) with a predominant stress urinary incontinence component." | 1.91 | TOT in combination with solifenacin or intravaginal prasterone in postmenopausal women with mixed urinary incontinence: A retrospective analysis in 112 patients. ( Cardella, G; Grossi, G; Loggia, M; Morgani, C; Palazzetti, PL; Sala, F; Schiavi, MC; Valensise, HCC; Zullo, MA, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collà Ruvolo, C | 1 |
| Gabrielli, O | 1 |
| Formisano, C | 1 |
| Califano, G | 1 |
| Manna, P | 1 |
| Venturella, R | 1 |
| Di Carlo, C | 1 |
| Sala, F | 1 |
| Loggia, M | 1 |
| Cardella, G | 1 |
| Morgani, C | 1 |
| Grossi, G | 1 |
| Zullo, MA | 1 |
| Valensise, HCC | 1 |
| Palazzetti, PL | 1 |
| Schiavi, MC | 1 |
2 other studies available for dehydroepiandrosterone and Urge Incontinence
| Article | Year |
|---|---|
Prasterone in the treatment of mild to moderate urge incontinence: an observational study.
Topics: Dehydroepiandrosterone; Female; Humans; Hyaluronic Acid; Male; Prospective Studies; Quality of Life; | 2022 |
TOT in combination with solifenacin or intravaginal prasterone in postmenopausal women with mixed urinary incontinence: A retrospective analysis in 112 patients.
Topics: Dehydroepiandrosterone; Female; Humans; Postmenopause; Quality of Life; Retrospective Studies; Solif | 2023 |